Einarson TR - Search Results

1

Pharmacotherapies for attention-deficit/hyperactivity disorder: expected-cost analysis.

Marchetti A, Magar R, Lau H, Murphy EL, Jensen PS, Conners CK, Findling R, Wineburg E, Carotenuto I, Einarson TR, Iskedjian M. Marchetti A, et al. Among authors: einarson tr. Clin Ther. 2001 Nov;23(11):1904-21. doi: 10.1016/s0149-2918(00)89086-4. Clin Ther. 2001. PMID: 11768842

2

Meta-analysis of the effect of latanoprost and brimonidine on intraocular pressure in the treatment of glaucoma.

Einarson TR, Kulin NA, Tingey D, Iskedjian M. Einarson TR, et al. Clin Ther. 2000 Dec;22(12):1502-15. doi: 10.1016/s0149-2918(00)83048-9. Clin Ther. 2000. PMID: 11192141

3

Pharmacoeconomic analysis of venlafaxine in the treatment of major depressive disorder.

Einarson TR, Addis A, Iskedjian M. Einarson TR, et al. Pharmacoeconomics. 1997 Aug;12(2 Pt 2):286-96. doi: 10.2165/00019053-199712020-00019. Pharmacoeconomics. 1997. PMID: 10170453 Clinical Trial.

4

Pharmacoeconomic evaluation of clozapine in treatment-resistant schizophrenia: a cost-utility analysis.

Oh PI, Iskedjian M, Addis A, Lanctôt K, Einarson TR. Oh PI, et al. Among authors: einarson tr. Can J Clin Pharmacol. 2001 Winter;8(4):199-206. Can J Clin Pharmacol. 2001. PMID: 11743592

5

Meta-Analyses of Cisapride, Omeprazole and Ranitidine in the Treatment of GORD: Implications for Treating Patient Subgroups.

Iskedjian M, Einarson TR. Iskedjian M, et al. Among authors: einarson tr. Clin Drug Investig. 1998;16(1):9-18. doi: 10.2165/00044011-199816010-00002. Clin Drug Investig. 1998. PMID: 18370513

6

Clinical and economic factors in the treatment of behavioural and psychological symptoms of dementia.

Hemels ME, Lanctôt KL, Iskedjian M, Einarson TR. Hemels ME, et al. Among authors: einarson tr. Drugs Aging. 2001;18(7):527-50. doi: 10.2165/00002512-200118070-00006. Drugs Aging. 2001. PMID: 11482746 Review.

7

Cost-effectiveness of treprostinil versus epoprostenol in patients with pulmonary arterial hypertension: a Canadian analysis.

Einarson TR, Granton JT, Vicente C, Walker J, Engel G, Iskedjian M. Einarson TR, et al. Can Respir J. 2005 Nov-Dec;12(8):419-25. doi: 10.1155/2005/719451. Can Respir J. 2005. PMID: 16331313 Free article.

8

Cost-minimization analysis of treprostinil vs. epoprostenol as an alternate to oral therapy non-responders for the treatment of pulmonary arterial hypertension.

Narine L, Hague LK, Walker JH, Vicente C, Schilz R, Desjardins O, Einarson TR, Iskedjian M. Narine L, et al. Among authors: einarson tr. Curr Med Res Opin. 2005 Dec;21(12):2007-16. doi: 10.1185/030079905X75104. Curr Med Res Opin. 2005. PMID: 16368052

9

Quality assessment of pharmacoeconomic abstracts of original research articles in selected journals.

Trakas K, Addis A, Kruk D, Buczek Y, Iskedjian M, Einarson TR. Trakas K, et al. Among authors: einarson tr. Ann Pharmacother. 1997 Apr;31(4):423-8. doi: 10.1177/106002809703100406. Ann Pharmacother. 1997. PMID: 9101002

10

Examining the Saskatchewan health drug database for antidepressant use: the case of fluoxetine.

Joffe RT, Iskedjian M, Einarson TR, O'Brien BJ, Stang MR. Joffe RT, et al. Among authors: einarson tr. Can J Clin Pharmacol. 2001 Fall;8(3):146-52. Can J Clin Pharmacol. 2001. PMID: 11574897

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters